ALCL

Clinical trials for ALCL explained in plain language.

Never miss a new study

Get alerted when new ALCL trials appear

Sign up with your email to follow new studies for ALCL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

Pfizer offers lifeline: ongoing crizotinib access for cancer patients

Disease control Ongoing

This study allows people with certain cancers (NSCLC, ALCL, IMT) who are already benefiting from crizotinib in a previous Pfizer study to keep receiving the drug after that study ends. About 27 participants will continue treatment while doctors monitor for side effects. The goal …

Matched conditions: ALCL

Phase: PHASE4 • Sponsor: Pfizer • Aim: Disease control

Last updated Jun 27, 2026 12:02 UTC

ALCL

Get alerted when new ALCL trials appear

Pfizer offers lifeline: ongoing crizotinib access for cancer patients